Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Thrombosis
Pharma
Mylan lays out $756M for EU rights to Aspen thrombosis meds
Mylan will lay out $756 million to acquire the EU rights to a suite of Aspen's sterile injectable anticoagulants in a portfolio-boosting move.
Kyle Blankenship
Sep 8, 2020 10:07am
AHA: J&J, Bayer still seeking answers in aborted Xarelto study
Nov 16, 2019 5:45pm
Boehringer balks as India clears Gennova's tenecteplase for stroke
Aug 19, 2016 10:37am